Leading the
next wave in psychedelics

Significant opportunities exist for investors as we advance psychedelic drug development. Become part of a movement to improve millions of lives.

Reach out to learn more

Market opportunity

Tryp is pursuing chronic pain and other indications to address the significant needs of patients. Because of the relatively high prevalence of these diseases, the market opportunity for the successful development and commercialization of our treatments is enormous.

Diagnosed Prevalence in the U.S.

Peak Annual Worldwide Sales Potential for Tryp

Source: Tryp Therapeutics Projections

Eager to learn more about Tryp Therapeutics?

Contact us

Market data

See how our stock is trading.

Gain visibility into the trading activity of our shares with key performance indicators and historic data.

Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Analyst Coverage

Analyst Coverage

Tryp Therapeutics Inc. is followed by the analyst listed above. To the best of Tryp Therapeutics Inc.'s knowledge, the above list reflects all firms and analysts that publish research on Tryp Therapeutics Inc. and they have agreed to have their names included on the list above. Please note that any opinions, estimates or forecasts regarding Tryp Therapeutics Inc.’s performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of Tryp Therapeutics Inc. or its management. Tryp Therapeutics Inc. does not by its reference imply its endorsement of or concurrence with such information, conclusions or recommendations.

Read our latest breakthroughs.

Learn more about our news and stay up to date on industry trends.

See all news


Join us for an event.

We regularly host and attend both virtual and in-person events.

See all events

Join us for an event.

We regularly host and attend both virtual and in-person events.

See all events

Investor resources

Get the latest information for investors.

See all resources

Investor presentation

Read the latest version of our investor deck, which includes information on our progress to date and our upcoming clinical activities.

Download now

Scientific literature

Learn more about the promise of psychedelics for chronic pain and other indications.

Read now